Evotec SE (ETR:EVT – Get Free Report) shares were up 0.9% during mid-day trading on Thursday . The stock traded as high as €8.10 ($8.44) and last traded at €8.00 ($8.33). Approximately 382,704 shares traded hands during trading, a decline of 72% from the average daily volume of 1,360,000 shares. The stock had previously closed at €7.93 ($8.26).
Evotec Stock Up 0.9 %
The firm has a market capitalization of $1.42 billion, a PE ratio of -8.33, a PEG ratio of 0.98 and a beta of 1.05. The company has a fifty day moving average price of €8.67 and a 200-day moving average price of €7.57. The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Read More
- Five stocks we like better than Evotec
- 5 discounted opportunities for dividend growth investors
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Why is the Ex-Dividend Date Significant to Investors?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Stock Sentiment Analysis: How it Works
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
